MVMartina Vitázková

Martina Vitázková

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martina Vitázková has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ZIF-8 Nanoparticles: Zinc Ion Release, In Vitro Biocompatibility, and Evaluation in Galleria mellonella

    by Nariman Alipanah, Orhan Sisman, Hana KaňkOvá, Martina VitázKová, José J. VelázQuez, Zuzana NeščákOvá

    Metal–organic frameworks (MOFs), and Zeolitic Imidazolate Framework-8 (ZIF-8) in particular, have found wide application in the therapeutic field. Their structure, size, and porosity can be tuned, and they can be synthesized using various methods. However, their biocompatibility and potential cytotoxicity remain insufficiently investigated. In this study, ZIF-8 nanoparticles were synthesized at room temperature using a rapid method with methanol as the solvent and characterized in terms of their chemical composition, structural properties, ion release behavior, and biocompatibility. The Zn ion release profile of ZIF-8 particles into Tris-HCl buffer medium was obtained through inductively coupled plasma optical emission spectroscopy (ICP-OES) under dynamic flow conditions, indicating a gradual and continuous release over 48 h. According to in vitro assays, MC3T3-E1 mouse preosteoblast cells maintained high viability at concentrations up to 100 μg·mL–1, while direct exposure of VH10 human fibroblast cells to 100 μg·mL–1 ZIF-8 reduced metabolic activity without significant membrane damage. However, no evident toxicity was observed in the eluate-based assay at this concentration. The findings were supported by the outcomes from the static ion release studies in DMEM cell culture medium, where ICP-OES showed that the level of Zn cations was lower than 9.5 μg·mL–1 in 100 μg·mL–1 ZIF-8 samples. The DNA fragmentation assay also indicated no detectable fragmentation at 100 μg·mL–1, suggesting the absence of apoptotic DNA damage in MC3T3-E1 cells under indirect exposure conditions. In addition, ZIF-8 was evaluated in vivo using the Galleria mellonella larval model, and samples up to 100 μg·mL–1 showed 100% survival and only minor reductions in health index score. The study underscores the importance of selecting appropriate methods for biocompatibility assessment, while also demonstrating the cytocompatibility of the investigated ZIF-8 nanoparticles, which may be associated with the relatively low measured Zn ion release.

  • Open Access

    Targeting multifunctionality in S53P4 silica-based bioactive glass by multi-ion substitution: Synthesis and characterization

    by Ertugrul Varlik, Martina Vitázková, Onat Basak, Seyma Sereflioglu, Orhan Sisman, Fatih Kurtuldu, Aldo R. Boccaccini, Martin Michálek


  • Open Access

    Low‐temperature sintered boron‐doped S53P4 bioactive glass scaffolds fabricated by robocasting

    by Ertugrul Varlik, Lenka Drotárová, Abel W. Ourgessa, Martina Vitázková, Qaisar Nawaz, Si Chen, Edgar B. Montufar, Dušan Galusek, Aldo R. Boccaccini, Martin Michálek

    This study investigates boron‐doped S53P4 bioactive glass (BG) scaffolds fabricated via robocasting in the context of bone regeneration strategies by comparing their mechanical performance and bioactive behavior to undoped S53P4 BG scaffolds. Three‐dimensional scaffolds with grid‐like macro architectures were fabricated using gelatin‐based composite inks containing S53P4 BG and 10 wt.% boron‐doped S53P4 BG (S53P4_10B). The scaffolds were sintered at optimized temperatures (900°C for S53P4 and 615°C for S53P4_10B), resulting in an average volumetric shrinkage of 33 vol%. Both scaffold types exhibited high porosity (∼71%) with pore sizes of 584 ± 7 µm (S53P4) and 608 ± 25 µm (S53P4_10B). Compressive strength values of 3.3 ± 1.7 MPa and 1.5 ± 0.4 MPa were respectively measured for S53P4 and for S53P4_10B BG scaffolds. Soaking in simulated body fluid for 14 days resulted in complete surface coverage with calcium‐phosphate‐rich phases, indicating high bioactivity. Antibacterial tests revealed that while crystallization reduced the inhibition zone of S53P4 scaffolds, S53P4_10B scaffolds exhibited significant antibacterial activity against E. coli and S. aureus . Cytocompatibility tests using MG‐63 and ST‐2 cell lines confirmed that scaffold extracts at concentrations ≤1% w/v were noncytotoxic. These results show that boron‐doped BG scaffolds possess bioactivity, antibacterial efficacy, and cytocompatibility, and suggest that their mechanical performance can be further tuned through scaffold design and sintering conditions.


  • Magnetic Mesoporous Bioactive Glass Nanocomposite for Enhanced Osteogenesis and Angiogenesis in Bone Tissue Engineering

    by Martina Vitázková, Fatih Kurtuldu, Saeed Sajjadi, Zuzana Neščáková, Lenka Buňová, Adriana Zeleňáková, Pavol Hrubovčák, Andrea Šoltýsová, Zulema Vargas-Osorio, Martin Michálek

    Bone regeneration is a complex process involving multiple biological pathways that require the simultaneous stimulation of osteogenesis and angiogenesis. This study presents a three-step fabrication process for a magnetic mesoporous bioactive glass nanocomposite (CoBTSp) designed to enhance bone tissue regeneration. The platform includes the synthesis of mesoporous bioactive glass nanoparticles codoped with cobalt (Co2+) and boron (B3+), the creation of well-defined core-shell systems (MBGNs@SiO2), and final decoration with superparamagnetic iron oxide nanoparticles (SPIONs). Its hierarchical structure enables the controlled and gradual release of bioactive ions, while the components improve biocompatibility and provide magnetic responsiveness for targeted bone therapy. Comprehensive physicochemical characterization confirmed the successful fabrication of CoBTSp, which exhibited superparamagnetic behavior for precise magnetic field localization. In vitro, assays demonstrated that CoBTSp enhanced angiogenic and osteogenic responses by upregulating VEGFA, HIF1A, FGF2, RUNX2, and COL18A1 gene expression. The nanocomposite promoted osteoblast differentiation and stimulated mineral deposition, showing excellent biocompatibility without inducing cytotoxic or genotoxic effects. These findings establish CoBTSp as a promising and versatile platform for bone regeneration, combining remarkable biological functions and controlled ion release with magnetic targeting for improved clinical outcomes. Nonetheless, future research should focus on in vivo testing to optimize therapeutic ion levels and further develop magnetic mesoporous bioactive glass nanocomposites for regenerative medicine.


  • Open Access

    High VEGF Secretion Using Co and B Co-doped Bioactive Mesoporous Glass Nanoparticles for Enhanced Angiogenesis

    by Martina VitázKová, Fatih Kurtuldu, Nurshen Mutlu, Kai Zheng, Yan Xu, Pavol ŠuLy, Lukáš MünSter, Zulema Vargas-Osorio, DušaN Galusek, Martin MichálEk

    This investigation presents a novel approach to engineering mesoporous bioactive glass nanoparticles (MBGNs) through selective ion doping. This method can significantly potentiate their physicochemical properties and biological performance. We elucidate the effects of boron (B) and cobalt (Co) doping, individually and in combination, on MBGNs’ structural, functional, and biocompatible characteristics. Using microemulsion-assisted sol–gel synthesis, we fabricated MBGNs with sizes ranging from 150 to 250 nm and shapes that shifted from spherical to more irregular shapes upon co-doping, as observed by SEM and TEM. We assessed the materials’ amorphous nature and molecular structure through XRD and FTIR, respectively, noting the preservation of bioactivity-associated Si–O–Si groups. This can influence the nucleation and growth of the mineral phases similar to those found in natural tissues, forming a bioactive coating on the material surface. Nitrogen adsorption–desorption isotherms confirmed a mesoporous structure with increased specific surface area upon co-doping. The release behavior of Ca and Si in simulated body fluids studied by ICP-OES indicated alterations after adding Co and B, modifying their release kinetics. Bone regeneration relies on osteogenesis and vascular network formation for nutrient and oxygen supply. This study highlights the synergistic effect of B and Co co-doping, enhancing both angiogenesis and osteogenesis beyond single-ion doping. Biocompatibility studies with MG-63 and HDFa cell lines indicated that B enhanced cell viability, while the viability effect of Co was concentration-dependent. Cytotoxicity was assessed through lactate dehydrogenase (LDH) assays and is shown in high concentrations in the case of reference and B-doped sample, which was significantly reduced in the case of co-doped material. The newly developed nanoparticles showed a 10-fold increase in vascular endothelial growth factor (VEGF) secretion compared to the control sample (p < 0.05, one-way ANOVA), as determined by enzyme-linked immunosorbent assay (ELISA) in treated cells. Based on present results, the co-doped system shows a strong potential impact on angiogenesis with no effect on cell cytotoxicity.